ENTA Conducting Clinical Trial of Investigational Regenerative Medication to Restore Hearing Function in Sensorineural Hearing Loss (SNHL) Patients

Press/Media

Period11 Mar 2022

Media coverage

1

Media coverage

  • TitleENTA Conducting Clinical Trial of Investigational Regenerative Medication to Restore Hearing Function in Sensorineural Hearing Loss (SNHL) Patients
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date11/03/22
    PersonsSujana Chandrasekhar